CID 135513050

Pyridazinone derivative, 8h

Structural Information

Molecular Formula
C23H25N5O6S2
SMILES
CC(C)CCN1C(=O)C(=C(C(=N1)C2=CC=CS2)O)C3=NS(=O)(=O)C4=C(N3)C=CC(=C4)OCC(=O)NC
InChI
InChI=1S/C23H25N5O6S2/c1-13(2)8-9-28-23(31)19(21(30)20(26-28)16-5-4-10-35-16)22-25-15-7-6-14(34-12-18(29)24-3)11-17(15)36(32,33)27-22/h4-7,10-11,13,30H,8-9,12H2,1-3H3,(H,24,29)(H,25,27)
InChIKey
ZHSXQHKIZOENIY-UHFFFAOYSA-N
Compound name
2-[[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-ylpyridazin-4-yl]-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-7-yl]oxy]-N-methylacetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

4
Patents

531.12463 Da
Monoisotopic Mass

2.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 532.13191 216.0
[M+Na]+ 554.11385 223.9
[M-H]- 530.11735 219.2
[M+NH4]+ 549.15845 220.1
[M+K]+ 570.08779 217.0
[M+H-H2O]+ 514.12189 208.6
[M+HCOO]- 576.12283 220.3
[M+CH3COO]- 590.13848 240.8
[M+Na-2H]- 552.09930 215.7
[M]+ 531.12408 222.6
[M]- 531.12518 222.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe